Ferrer, Leti and Oryzon to collaborate in R&D
Catalan Economy
21 Nov 2009
Pharmaceutical companies Ferrer and Leti and biotech firm Oryzon have announced the creation of the Oncochip alliance to further develop cancer research in Catalonia. Madrid-based Ingenasa and Navarra’s CIMA are also to participate in the project.
With a budget of over EUR 20 million, Oncochip will focus on the design of therapies for early diagnosis of ovarian cancer, melanoma and colon cancer. Oryzon specializes in the detection of cancer biomarkers and is already working with Reig Jofré on uterine cancer research.
Ferrer, Leti and Oryzon also plan to create a new partnership next year to develop nanotechnology projects.
Source: Expansión Cataluña 16/11/2009
More News and Success Stories.
-
19 Nov 2026
See more Barcelona ranks second in the EU for artificial intelligence, according to The Observer’s AI Cities IndexBarcelona ranks second in the EU for artificial intelligence, according to The Observer’s AI Cities Index
-
13 Nov 2026
See more ACCIÓ-Catalonia Trade & Investment named a Startup Ecosystem Star 2026ACCIÓ-Catalonia Trade & Investment named a Startup Ecosystem Star 2026
-
04 Nov 2026
See more Catalonia’s silver economy now includes over 1,000 companies and generates more than €13.3 billion in revenueCatalonia’s silver economy now includes over 1,000 companies and generates more than €13.3 billion in revenue
-
29 Oct 2026
See more Catalonia’s cybersecurity sector surpasses €1.7 billion in revenue, growing 19.8%Catalonia’s cybersecurity sector surpasses €1.7 billion in revenue, growing 19.8%

